Jane G. Binz
Research Triangle Park Foundation(US)GlaxoSmithKline (United States)(US)
Publications by Year
Research Areas
Peroxisome Proliferator-Activated Receptors, Adipose Tissue and Metabolism, Metabolism, Diabetes, and Cancer, Drug Transport and Resistance Mechanisms, Diet and metabolism studies
Most-Cited Works
- → Identification of a Nonsteroidal Liver X Receptor Agonist through Parallel Array Synthesis of Tertiary Amines(2002)430 cited
- → Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis(2003)381 cited
- → A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat.(1999)168 cited
- → The RXR agonist LG100268 causes hepatomegaly, improves glycaemic control and decreases cardiovascular risk and cachexia in diabetic mice suffering from pancreatic beta-cell dysfunction(1999)84 cited
- → GI262570, a Peroxisome Proliferator-Activated Receptor γ Agonist, Changes Electrolytes and Water Reabsorption from the Distal Nephron in Rats(2005)75 cited
- → The Effect of PPARα, PPARδ, PPARγ, and PPARpan Agonists on Body Weight, Body Mass, and Serum Lipid Profiles in Diet-Induced Obese AKR/J Mice(2007)69 cited
- → Effects of the cFMS Kinase Inhibitor 5-(3-Methoxy-4-((4-methoxybenzyl)oxy)benzyl)pyrimidine-2,4-diamine (GW2580) in Normal and Arthritic Rats(2008)55 cited
- → Synergistic Effects of a GPR119 Agonist with Metformin on Weight Loss in Diet-Induced Obese Mice(2015)19 cited
- → Antidiabetic efficacy of GI262570 in two rodent models of type 2 diabetes(2000)1 cited